Scienture Holdings, Inc. (FRA:4E4)

Germany flag Germany · Delayed Price · Currency is EUR
0.372
+0.042 (12.73%)
At close: Dec 4, 2025
Market Cap 21.31M
Revenue (ttm) 556.89K
Net Income (ttm) -17.52M
Shares Out n/a
EPS (ttm) -1.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.372
Previous Close 0.330
Day's Range 0.372 - 0.372
52-Week Range 0.288 - 3.640
Beta n/a
RSI 45.36
Earnings Date Nov 19, 2025

About Scienture Holdings

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potas... [Read more]

Industry Computer Programming, Data Processing, And Other Computer Related Services
Employees 19
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4E4
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.